The Recall Desk
Agency classClass IIOur severity:ModerateFDA (Drugs)·D-0147-2027·Announced 2026-11-11

Victory Medical Center Pharmacy Recalls Tirzepatide/B6 Vials Due to Processing Controls

Victory Medical Center Pharmacy is recalling 104 vials of Tirzepatide/B6 (MDV) 25mg/10mg/mL due to a lack of processing controls. The product was distributed in Colorado, Florida, and Texas.

The agency’s classification

FDA (Drugs): Class II

Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.

This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work

What this means for you

Our assessment, not the agency’s: severity 2/5 (Moderate).

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: The recall is classified as FDA Class II due to a lack of processing controls. The source does not report any illnesses, injuries, or deaths.

Plain-English summary

Victory Medical Center Pharmacy in Austin, Texas, is recalling 104 vials of Tirzepatide/B6 (MDV) 25mg/10mg/mL. The recall was initiated because of a lack of processing controls. The affected product is identified by Lot 2012330 with an expiration date of 10/24/2026.

The recalled product was distributed to customers in Colorado, Florida, and Texas. The FDA has classified this recall as Class II, which indicates that use of or exposure to the violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.

Consumers who have this product should stop using it and contact their healthcare provider or the pharmacy for further instructions. The source text does not report any illnesses, injuries, or deaths associated with this recall.

The recalled product

Product
TIRZEPATIDE/B6 (MDV) 25MG/10MG/ML **1ML**, VMC, Victory Medical Center Pharmacy, Austin, Texas
Affected units
104

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (3)

  • Lot
  • expiry: Lot 2012330
  • exp 10/24/2026

Distribution

Distributed in 3 states:

Similar recalls